Authors
Latest:
Medicare Coverage of Buprenorphine-Naloxone Film Surrounding Generic EntryMedicare plans are replacing brand-name buprenorphine-naloxone film with its generic equivalents, resulting in a decrease in out-of-pocket cost faced by enrollees with opioid use disorder.
Latest:
Geographic Variability of Medicaid Acceptance Among Allergists in the USThe proportion of allergists accepting Medicaid in the US varied significantly among and within states.
Latest:
The Role of Advanced Technologies in Improving Diabetes OutcomesThis article reviews underlying barriers to health care access and discusses how a value-based diabetes care model could improve patient outcomes and reduce long-term costs.
Latest:
Avian Influenza: Prevention, Progress, and Public Health PrioritiesTo learn more about the recent bird flu outbreaks, we spoke with Asha Shah, MD, director of infectious diseases and epidemiologist at Stamford Hospital.
Latest:
Using a Brief Tool to Assess Healthy School Environments: A Pilot StudyThe authors evaluated a brief assessment tool that accountable care organizations can use to help elementary schools improve student nutrition and increase physical activity.
Latest:
Patients’ Access to 2018 FDA-Approved Drugs 1 Year Post Approval2018 was a landmark year for new drug approvals. However, patients’ access to these novel drugs varied by drug category and enrolled health plan.
Latest:
A Novel Approach to Attribute Responsible Physicians Using Inpatient ClaimsThe authors propose a novel approach in which physicians’ responsibility for inpatient stays is expressed through physician-specific attribution ratios informed by patient characteristics.
Latest:
Social Determinants of Health and High-Cost Utilization Among Commercially Insured PopulationResidence in a more disadvantaged neighborhood was associated with higher likelihood of being a high-cost utilizer among older adults and lower likelihood among younger adults.
Latest:
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency CareCare delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Latest:
Challenges With Implementing the Diabetes Prevention Program for Medicare Beneficiaries in an Integrated Health SystemThis study presents challenges of implementing the CDC-approved Diabetes Prevention Program for Medicare beneficiaries at a large, integrated health care delivery system.
Latest:
Utilization of Low- and High-Value Health Care by Individuals With and Without Cognitive ImpairmentLow-value service utilization is common among all older adults, and utilization of some high-value services decreases after the onset of cognitive decline.
Latest:
Physician Preferences for an Electronic Lung Cancer Screening Decision AidThis qualitative study on primary care physicians yielded suggestions that can inform the design of an effective lung cancer screening decision aid tool and implementation into the electronic health record.
Latest:
Doctors Hate Deductibles: Physicians Pay Thousands to Avoid High DeductiblesNinety percent of physicians did not select a high-deductible health plan although it would save them $1500 to $4000 per year regardless of health spending.
Latest:
An Integrated Practice Unit Tool for the Military Health SystemResearchers developed and tested an assessment tool to measure coordinated care for traumatic brain injury against the criteria of an integrated practice unit.
Latest:
Real-world HIV Diagnostic Testing Patterns in the United StatesThis retrospective study evaluated real-world implementation of the updated CDC HIV algorithm in a large US laboratory.
Latest:
FDA Approves Acoramidis for ATTR-CMWith approval, acoramaidis (Attruby; BridgeBio Pharma) becomes the first agent with a label specifying near-complete stabilization of transthyretin (TTR).
Latest:
Elraglusib Granted FDA Orphan Drug Status in Soft Tissue SarcomaThe FDA granted orphan drug designation for elraglusib, a novel drug for treating advanced soft tissue sarcoma.
Latest:
Treatment Modification After Initiating Second-Line Medication for Type 2 DiabetesAmong adults with type 2 diabetes who started noninsulin second-line therapy, most modified treatment within 1 year. Discontinuation was by far the most common modification.
Latest:
Agreement Among Measures Examining Low-Value Imaging for Low Back PainThis study demonstrates the need for additional consensus surrounding how to translate guideline recommendations to administrative measures assessing imaging overuse for acute low back pain.
Latest:
Systemic Treatments for Advanced Prostate Cancer: Relationship Between Health Insurance Plan and Treatment CostsThe authors examine how insurer and patient out-of-pocket payments for advanced prostate cancer differ by drug and health plan type and describe the relationship between these payments and utilization.
Latest:
Health Care Resource Utilization, Quality Metrics, and Costs of Bladder Cancer Within the Oncology Care ModelSpending on novel therapies in high-risk bladder cancer had minimal impact on Oncology Care Model payments to practices, according to this cohort study and an average performance estimation.
Latest:
Privately Negotiated Facility Fees at Ambulatory Surgery Centers and HospitalsPrivate negotiated facility fees at hospitals are on average double the ambulatory surgery center facility fees for common outpatient procedures.
Latest:
Timely Preterm-Birth Prediction Among Pregnant Women in Medicaid Without Preterm-Birth HistoryA novel prediction model is developed that accurately predicts preterm birth in a timely manner among pregnant women in Medicaid without preterm-birth history.
Latest:
TCD Screening and Spending Among Children With Sickle Cell AnemiaA substantial proportion of families of privately insured children with sickle cell anemia pay more than $100 for essential stroke screenings, a high-value service.
Latest:
Cost-effectiveness of Case Management: A Systematic ReviewThis systematic review found that studies of case management interventions have adequate quality and, in many cases, show cost-effective or even cost-saving results.
Latest:
Better Data Is Needed to Tackle Health EquityThe US federal government is finally updating its standards for reporting data on race and ethnicity – and it’s an urgently needed chance to enable a national overview of crucial data on health inequities
